HCG completes transaction under BTA, SSA with Strand Life Sciences

10 Feb 2018 Evaluate

Healthcare Global Enterprises (HCG) has concluded the transactions under the Business Transfer Agreement (BTA) and the Share Subscription Agreement (SSA) entered with Strand Life Sciences. Further, Strand Life Sciences has received investments from Taurus QC Investment Holdings and Healthquad Fund I; and the shareholding of the company in Strand Life Sciences stands at 38.2% on a fully diluted basis.

Earlier in January, HCG had entered into definitive agreements providing for a business combination of its Triesta Sciences business unit (Triesta Sciences), with Strand Life Sciences, a company incorporated under the Companies Act, 1956. The company had entered into a BTA, a SSA and a Shareholders’ Agreement (SHA) with Strand Life Sciences in relation to the proposed Business Combination.

HealthCare Global Enterprises is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.